Benzodiazepine Dose Conversion: Clonazepam to Lorazepam
Clonazepam 1 mg three times daily (3 mg/day total) converts to approximately lorazepam 1.5 mg three times daily (4.5 mg/day total), using a 2:3 potency ratio where clonazepam is roughly 1.5-2 times more potent than lorazepam.
Conversion Rationale
The conversion between these benzodiazepines is based on established relative potencies, though no direct guideline explicitly addresses this specific adult outpatient conversion. The pediatric neonatal withdrawal guideline 1 provides the only formal conversion framework, stating that lorazepam is twice as potent as midazolam. While this doesn't directly address clonazepam-to-lorazepam conversion, clinical pharmacology establishes that:
- Clonazepam is approximately 1.5-2 times more potent than lorazepam based on receptor binding affinity and clinical dosing patterns
- Using a conservative 2:3 ratio (clonazepam:lorazepam), multiply the clonazepam dose by 1.5
Calculation:
- Current dose: Clonazepam 1 mg TID = 3 mg/day
- Conversion: 3 mg × 1.5 = 4.5 mg lorazepam/day
- Divided dosing: 1.5 mg lorazepam three times daily
Critical Considerations for Safe Conversion
Half-Life Differences Matter
Clonazepam has a significantly longer half-life (18-50 hours) compared to lorazepam (10-20 hours) 2. This means:
- Start with the calculated equivalent dose but monitor closely for the first 3-5 days as clonazepam clears from the system
- Patients may experience breakthrough symptoms between lorazepam doses due to shorter duration of action
- Consider giving a slightly higher bedtime dose (e.g., 1 mg-1.5 mg-2 mg dosing pattern) to maintain overnight coverage
Withdrawal Risk
The 2012 pediatric guideline 1 emphasizes that "signs and symptoms of withdrawal from benzodiazepine therapy can be delayed" and recommends weaning by 10-20% per day when discontinuing. For conversion:
- Do NOT abruptly stop clonazepam and start lorazepam
- Use a brief overlap period: Start lorazepam at full calculated dose while tapering clonazepam by 50% for 2-3 days, then discontinue clonazepam
- This prevents withdrawal symptoms while establishing therapeutic lorazepam levels
Dosing Frequency Adjustment
Given lorazepam's shorter half-life, some patients may require four times daily dosing (every 6 hours) rather than three times daily for equivalent symptom control, particularly if treating anxiety or panic disorder. The FDA label 3 supports dosing intervals as frequent as every 6-8 hours.
Alternative Approach: Start Lower and Titrate
Given the serious risk of oversedation when converting between benzodiazepines, a safer clinical approach is:
- Start with lorazepam 1 mg TID (3 mg/day total - slightly lower than calculated equivalent)
- Overlap with reduced clonazepam (0.5 mg TID) for 48-72 hours
- Discontinue clonazepam and assess response
- Titrate lorazepam up to 1.5 mg TID if needed based on symptom control over the next week
Common Pitfalls to Avoid
- Do not use a 1:1 conversion ratio - this significantly underdoses and risks breakthrough symptoms or withdrawal
- Do not ignore the indication - if converting for panic disorder, the FDA label 4 notes clonazepam's optimal dose is 1 mg/day, suggesting the original 3 mg/day may already be higher than necessary
- Monitor for respiratory depression - the 2018 ESMO guideline 5 warns about combining benzodiazepines with other CNS depressants, and the 2025 geriatric study 6 found benzodiazepines, particularly midazolam, had the worst safety profile with increased respiratory events
- Assess for hepatic impairment - lorazepam clearance is less affected by liver disease than other benzodiazepines 3, but dose reduction may still be needed
Duration of Action Advantage
Research demonstrates that lorazepam has a longer duration of anticonvulsant action (up to 72 hours) compared to clonazepam's 24 hours in acute settings 2, though this applies primarily to single-dose scenarios rather than chronic dosing. For chronic anxiety or seizure management, the practical difference is lorazepam's shorter elimination half-life requiring more frequent dosing or acceptance of fluctuating blood levels.